Collagen Receptors as Potential Targets for Novel Anti-Platelet Agents

E-ISSN： 1873-4286|13|26|2673-2683

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.13, Iss.26, 2007-01, pp. : 2673-2683

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Platelet Activation, and Antiplatelet Targets and Agents: Current and Novel Strategies

By Xiang Yao-Zu Xia Ye Gao Xiu-Mei Shang Hong-Cai Kang Li-Yuan Zhang Bo-Li

Drugs, Vol. 68, Iss. 12, 2008-01 ,pp. : 1647-1664

Adis International

Access to resources Recommend Favorite

Novel Integrin-Specific Targets for Anti-Platelet Therapies

Current Pharmaceutical Design, Vol. 10, Iss. 14, 2004-05 ,pp. : 1603-1609

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Anti-platelet Agents for the Treatment of Stable Angina Pectoris

Current Pharmaceutical Design, Vol. 19, Iss. 9, 2013-03 ,pp. : 1581-1586

Bentham Science Publishers

Access to resources Recommend Favorite

A CAPE analogue as novel antiplatelet agent efficiently inhibits collagen-induced platelet aggregation

By Zhou Kai Li Xiaoli Du Qin Li Defeng Hu Mo Yang Xiaojia Jiang Qi Li Zhubo

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 69, Iss. 8, 2014-08 ,pp. : 615-620

Govi-Verlag

Access to resources Recommend Favorite

Proteomics to Unravel Platelet-Related Diseases and Identify Novel Anti-Platelet Drugs

Current Medicinal Chemistry, Vol. 19, Iss. 27, 2012-09 ,pp. : 4662-4670

Bentham Science Publishers

Access to resources Recommend Favorite